A CenterWatch survey shows drug sponsors have continued to improve relationships with investigative sites by focusing on strategies to improve site quality and performance.
Clavis Pharma announces that Robert J. Spiegel, MD, has been elected to its board of directors.
Antisense Pharma GmbH announced the granting of patents for an application system, which for the first time allows long-term and outpatient administration of therapeutic substances into brain tissue using the Convection Enhanced Delivery (CED).
Nycomed's licensing partner Sunovion Pharmaceuticals Inc. announced the U.S. Food and Drug Administration (FDA) has accepted the filing of the New Drug Application (NDA) submitted for ciclesonide nasal aerosol in a hydrofluoroalkane (HFA) formulation.
Freeslate Inc.’s Automation Studio 8.3 software, a component of its Lab Execution and Analysis (LEA) software suite, improves R&D productivity by automating and controlling multiple laboratory instruments with a single software interface.
Micronic’s Track-IT is an LIMS/LIS solution made for scientists, which helps re-organize and track tubes and samples.
IDBS, a global provider of data management, analytics, and modeling solutions, and ChemAxon, a provider of cheminformatics software for the life sciences industry, announced the extension of their relationship.
A Johnson & Johnson subsidiary must pay South Carolina $327 million for deceptive marketing of an antipsychotic drug, a Spartanburg County judge ruled June 3.
Novartis says it has received European Union approval for its eye drug Lucentis to be used as a treatment for vision loss caused by blocked retinal veins.
Trion Pharma announced results from two studies demonstrating catumaxomab’s capacity to activate the immune system in a way that otherwise can only be achieved through vaccination.
Shimadzu Scientific Instruments’ ultra-fast mass spectrometry (UFMS) delivers speed without sacrificing sensitivity, resolution or mass range.
Thermo Fisher Scientific Inc.’s hybrid mass spectrometer, the Orbitrap Elite, offers a resolving power of 240,000 and a range of fragmentation techniques, helping customers explore challenges in proteomics, metabolomics, lipidomics and metabolism applications.
IonSense, Inc.’s ID CUBE Source with OpenSpot sample card can speed the analysis of new materials being created by synthetic and medicinal chemists in universities and pharmaceutical companies.
Thermo Fisher Scientific Inc.’s Q Exactive benchtop quadrupole-Orbitrap brings together quadrupole precursor selection and high-resolution accurate mass Orbitrap mass analysis to deliver quantitative workflows.